Dr. Robson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Avenue
Beth Israel Deaconess Medical Center
Boston, MA 02215Phone+1 617-632-1070Fax+1 617-632-1861
Summary
- Physician Scientist with expertise in Hepatology and Inflammation.
Education & Training
- Beth Israel Deaconess Medical CenterPost-Doctoral Fellowship, 1993 - 1996
- University of Cape TownPhD, 1989
- Kings College HospitalMRCP, 1982 - 1983
- University of Cape Town Faculty of MedicineClass of 1978
Certifications & Licensure
- MA State Medical License 1997 - 2026
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Plenary and Keynote Lectures PURINES2018, PURINES2022, 2018, 2022
- John Hedley-Whyte Lectureship Anesthesia, BIDMC, 2021
- Subcommittee of Professors Harvard Medical School, 2018, 2020-2021
- Join now to see all
Clinical Trials
- Identification of Genetic Causes of Calcific Aortic Valve Disease Start of enrollment: 2018 Sep 25
- Purinergic Signaling and the Postmenopausal Heart Start of enrollment: 2019 Jul 01
Publications & Presentations
PubMed
- 339 citationsMetabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-αIvan D. Mascanfroni, Maisa C. Takenaka, Ada Yeste, Bonny Patel, Yan Wu
Nature Medicine. 2015-06-01 - 12 citationsRole of P2X4 Receptor in Mouse Voiding FunctionWeiqun Yu, Warren G. Hill, Simon C. Robson, Mark L. Zeidel
Scientific Reports. 2018-01-30 - 490 citationsNegative feedback control of neuronal activity by microgliaAna Badimon, Hayley J. Strasburger, Pinar Ayata, Xinhong Chen, Aditya Nair
Nature. 2020-10-15
Journal Articles
- Adenosine generation by CD39 and CD73 on T regulatory cells mediates immune suppressionDeaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen JF, Enjyoji K, Linden J, Oukka M, Kuchroo VK, Strom TB, Robson SC, The Journal of Experimental Medicine, 1/1/2007
- Purinergic Signaling during InflammationEltzschig HK, Sitkovsky MV, Robson SC, N Engl J Med, 12/13/2012
- Pulmonary natural killer T cells play an essential role in mediating hyperoxic acute lung injuryNowak-Machen M, Schmelzle M, Hanidziar D, Junger W, Exley M, Otterbein L, Wu Y, Csizmadia E, Doherty G, Sitkovsky M, Robson SC, Am J Respir Cell Mol Biol, 5/1/2013
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Lower Risk of Cardiac Rupture in CD39 Null Mice Post-myocardial InfarctionOgawa M, Ogawa N, Nakayama M, Csizmadia E, Enjyoji K, Kohzuki M, Robson SC, J. American College of Cardiology, 1/1/2005
- Adenosine A1 and A2A Receptors. CD39/CD73KO Influence Granulomatousresponses to BCGKara FM, Montesinos MC, Mor A, Robson SC, Thompson L, Cronstein BN, 8th International Symposium on Adenosine and Adenine Nucleotides, Ferrara, Italy, 5/1/2006
- Transcription Factor YY1 and the Retinoblastoma Protein Are Downstream Targets of CD39/ENTPD1 Signaling Pathways during Liver RegenerationWu Y, Imai M, Sun X, Csizmadia E, Enjyoji K, Choi C, Robson SC,Usheva A, Hepatology, 1/1/2005
- Join now to see all
Lectures
- Vascular Biology of CD39 and Transplantation TopicsDepartment of Gastroenterology, BIDMC - 1/1/2013
- Vascular Bed-specific Characteristics of Endothelial CellsDepartment of Gastroenterology, Mount Sinai Hospital, NY - 1/1/2013
- Purinergic Signaling in the LiverLondon, UK - 1/1/2013
- Join now to see all
Other
- Hepatic Xenotransplantation. Transplant Report
1/1/1995 - Contributions to Reports in Cape Times, Hepatitis B Immunizations and Liver TransplantationRobson
1/1/1993 - Audio-mix, and Pathways to HealthRadio Today
1/1/1993 - Join now to see all
Grant Support
- T cell genotype/phenotype influence on atherosclerotic cardiovascular disease.NIH2023–2027
- Targeting ENTPD3 to boost extracellular ATP and inflame tumors.Emerson Collective CRF2021–2023
- PGC-1α, Purines and the Postmenopausal Heart.NIH NIA2021–2023
- DAMP-Mediated Innate Immune Failure and Pneumonia .....DoD2016–2022
- Directed Purinergic Signaling as Immunotherapy in LeukemiaNIH NCI2018–2020
- Engineering Inhibitory Antibodies To Ectoenzymes For Cancer TreatmentNational Cancer Institute2012
- Thromboregulatory Barriers To XenotransplantationNational Institute Of Allergy And Infectious Diseases2000–2011
- Purinergic ThromboregulationNational Heart, Lung, And Blood Institute2009–2010
- Thromboregulatory Strategies To Prolong Xenograft Survival.National Institute Of Allergy And Infectious Diseases2006–2009
- Vascular Topography Of Cd39/NtpdasesNational Heart, Lung, And Blood Institute2004–2008
- Core--Histological SupportNational Heart, Lung, And Blood Institute2004–2008
- Functional Analysis Of Vascular NtpdasesNational Heart, Lung, And Blood Institute2000–2007
- Thromboregulatory Strategies To Prolong XenograftsNational Institute Of Allergy And Infectious Diseases2005
- Vascular Ntpdases And TransplantationNational Heart, Lung, And Blood Institute2001–2004
- Vascular Ecto Adpases And TransplantationNational Heart, Lung, And Blood Institute1997–2000
Committees
- Member, SOP HMS 2018 - 2021
Research History
- Vice Chair Research AnesthesiaDirector of Center for Inflammation Research2019 - Present
Professional Memberships
- AASLDMember
Other Languages
- Dutch
Industry Relationships
- Scientific Founder, ePURINES2018 - Present
- Scientific Founder, Purinomia2017 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: